SFPQ/PSF-TFE3 Renal Cell Carcinoma Mimicking TFEB-Rearranged Renal Cell Carcinoma and Co-Occurring With High-Grade Urothelial Carcinoma: A Case Report
Renal cell carcinoma • SFPQ/PSF-TFE3 renal cell carcinoma Symptoms: Hematuria • recurrent urinary tract infections • urinary urgency • weight loss Clinical Procedure: -Specialty: PathologyObjective: Rare disease Background:Transcription factor E3 (TFE3)-rearranged renal cell carcinoma is a rare subtype of renal tumor that relatively more frequent in the pediatric population.Histologically, it typically presents as a papillary neoplasm composed of clear epithelial cells with numerous psammoma bodies.Transcription factor EB (TFEB)-rearranged renal cell carcinoma is an even rarer entity, classically characterized by biphasic cellular morphology, rosette-like structures, and eosinophilic basement membrane-like material. Case Report:We describe a case of splicing factor proline-and glutamine-rich (SFPQ)/polypyrimidine tract-binding proteinassociated splicing factor (PSF)-TFE3 renal cell carcinoma confirmed by RNA sequencing that morphologically mimicked TFEB-rearranged renal cell carcinoma in a 66-year-old woman with concurrent high-grade urothelial carcinoma of the urinary bladder and ureter. Conclusions:This case expands the recognized histologic spectrum of TFE3-rearranged renal cell carcinoma and highlights the critical role of molecular testing in establishing a definitive diagnosis.
Authors
- Frances Xiuyan Feng (ORCID: https://orcid.org/0009-0008-6813-0027)
- Corbin Jeffrey Eule (ORCID: https://orcid.org/0000-0002-8430-1040)
- Xin Zhou
- Janet Kukreja
Institutions
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- American Journal of Case Reports
- Published
- 2026-11-16
- DOI
- https://doi.org/10.12659/ajcr.954845
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00